Clinical Trial Detail

NCT ID NCT01248962
Title Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

Therapies

Carboplatin

Age Groups: adult

No variant requirements are available.